The application for MIT DC Grand Hack 2019 is now closed.

Interested in partnering, supporting, or sponsoring our MIT Grand Hacks around the world? Find out more here about opportunities available or contact us here or by emailing us directly at grandhack@mit.edu.

MIT Hacking Medicine is proud to partner with Samsung for the MIT DC Grand Hack! 

Interested in disrupting healthcare?

Join MIT Hacking Medicine as we bring the MIT Grand Hack to Washington D.C.! This is the weekend to brainstorm and build innovative solutions with hundreds of like-minded engineers, clinicians, designers, developers and business people. Within our multi-theme event, there is sure to be a healthcare challenge for everyone! 

Interested in helping out? You can partner with us, become a sponsor, or sign up to be a mentor! Email dcgrandhack@mit.edu for more information!

Visit the Samsung developer’s website to check out some of the resources being offered at our event!

Twitter Hashtag: #DCGrandHack2019

Watch and listen to the full video below from our MIT Grand Hack in Boston from April 2018!

TRACKS

GH19 DC Graphics_track icon - access - white

Access to Healthcare

Many people around the world are limited in their access to necessary healthcare services, thereby increasing their risk of poor health outcomes and serious complications. These barriers to healthcare are out of the patient’s control, largely stemming from economic disparities, lack of education, and lack of availability of services in their geographical area. Veterans, in particular, can often have difficulty receiving timely checkups due to high demand and the distance to VA clinics. How can we work for these underserved populations to deliver basic healthcare needs? What simple technologies can be set up to introduce clinical care at minimal cost? How can we improve access to continuing care for veterans who are unable to make it to their closest VA hospital? This track will work together to ensure broader access to care for underserved populations – exploring the source of pain points in delivering healthcare and introducing ways to circumvent economic and geographical barriers.

GH19 DC Graphics2_track icon - mental - white

Mental Health & Professional Burnout

Whether directly or indirectly from depression, anxiety, OCD, PTSD, substance use, personality disorders, loneliness or burnout, millions of people live with a mental health condition. Join others in the mental health track & professional burnout track to tackle the broad range of pain points surrounding this complex field. How can we better detect, diagnose, and prevent these mental health conditions that often occur from professional settings? How can we help veterans suffering from conditions such as PTSD improve their health? How can we continue to de-stigmatize mental health conditions and ensure that our society better accommodates for those who live with chronic mental health conditions? How can we ensure broader access to care, especially for vulnerable populations, and improve retention in treatment?​

GH19 DC Graphics2_track icon - rare - white

Rare & Orphan Diseases

A rare disease is defined as a condition that affects fewer than 200,000 people. Rare diseases become orphan diseases when drug companies are no longer interested in developing treatments against them. With the low prevalence, how can we work to prioritize cures for rare and orphaned diseases? What technologies can be set up to better diagnose & treat these diseases? How do we improve the design & implementation of drug development programs focused on rare diseases ? Can we enable patients to accurately self-diagnose their rare disease, and are there ways to efficiently share knowledge among researchers to increase understanding and advance treatment? This track will focus on diseases that impact a relatively small portion of the world’s population – emphasizing solutions that help with the knowledge transfer, diagnosis, and treatment of rare diseases while ensuring these solutions are accessible to those who may have social, psychological, economic, or cultural roadblocks.​

KEYNOTE SPEAKERS

Dr. Clancy serves as the VHA Deputy Under Secretary for Health (DUSH) for Discovery, Education & Affiliate Networks (DEAN), effective July 22, 2018. Prior to her current position, she served as the Executive in Charge, Veterans Health Administration, with the authority to perform the functions and duties of the Under Secretary for Health. As the Executive in Charge, Dr. Clancy directed a health care system with an annual budget of approximately $68 billion, overseeing the delivery of care to more than 9 million enrolled Veterans. Previously, she served as the Interim Under Secretary for Health from 2014-2015. Dr. Clancy also served as the VHA Deputy Under Secretary for Health for Organizational Excellence, overseeing VHA’s performance, quality, safety, risk management, systems engineering, auditing, oversight, ethics and accreditation programs, as well as ten years as the Director, Agency for Healthcare Research and Quality. In 2015, Dr. Clancy was selected as the Outstanding Federal Executive of the Year by Disabled American Veterans, and in 2018, she was selected as one of the Top 50 Physician Executives by Modern Healthcare.She is a highly experienced and nationally recognized physician executive. Dr. Clancy holds an academic appointment at George Washington University School of Medicine and serves as Senior Associate Editor, Health Services Research. She served as member of the National Quality Forum, Board of Directors, as the Chair of the AQA Alliance and served on the Board of Governors, Patient-Centered Outcomes Research Institute. An elected member of the National Academy of Medicine, Dr. Clancy was most recently presented with the 2014 Quality Champion Award, National Committee for Quality Assurance and was also named as Honorary Fellow, American Academy of Nursing.

John Godfrey is Senior Vice President of Public Policy for Samsung Electronics America, a U.S. subsidiary of Samsung Electronics Co. headquartered in South Korea. Based in Washington, D.C., he leads Samsung’s public policy team in engagement with government and industry, focusing on communications policy, digital television, wireless spectrum, health care, environment, broadband, cybersecurity, privacy and other areas. An active participant in the Consumer Technology Association (CTA), Godfrey is a member and past chair of the CTA Foundation’s Board of Trustees and CTA’s Video Division Board, among other groups. He is also a past chairman of the Board of Directors of the Advanced Television Systems Committee, the standards developing organization for digital television broadcasting. He served on the Federal Communications Commission’s Downloadable Security Technology Advisory Committee in 2015 and the U.S. Access Board’s Electronic and Information Technology Accessibility Advisory Committee in 1998-1999. Prior to joining Samsung in 2006, Godfrey was vice president of government affairs for Pioneer North America; and previously, he was director of government affairs for Sony Electronics. Earlier, he was with the Information Technology Industry Council, a trade association of leading information technology companies; the National Research Council, the policy research arm of the National Academies of Sciences and Engineering; and SRI International.

Dr. Jon Bloom is a board-certified physician and entrepreneur with over 15 years of experience in technology development, patient monitoring, biomedical research, and health care delivery.  He is the chief executive officer of Podimetrics, a care management company with the leading solution to help prevent diabetic foot ulcers, one of the most debilitating and costly complications of diabetes. Dr. Bloom co-founded Podimetrics in 2011 while a student at the MIT Sloan School of Management. Podimetrics combines an FDA-cleared SmartMat™ with wraparound care management to spot signs of ulcers, on average, five weeks before they usually would present clinically. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients and achieves unparalleled outcomes saving limbs, lives, and money. Dr. Bloom served as a Clinical Assistant Professor and staff anesthesiologist at the University of Pittsburgh Medical Center. He also served as the Director of Global Medical Affairs for Covidien’s Respiratory and Monitoring Solutions division in Boulder, Colorado. Dr. Bloom is a diplomate of the American Board of Anesthesiology, completing residency at the Massachusetts General Hospital. He has co-authored more than 20 peer-reviewed publications with a primary focus on health care economics and perioperative complications. Prior to his career in medicine Dr. Bloom studied cytochrome P450 drug metabolism at The Scripps Research Institute.

Sharad K. Verma, PhD, is the Director of Research and Development for the Neurofibromatosis TherapyAcceleration Program (NTAP), and an Assistant Professor in the Department of Neurology, at The JohnsHopkins University School of Medicine. In these roles, Dr. Verma oversees a portfolio of diverse research projects  focused on the discovery and development of therapeutics for the treatment ofneurofibromatosis type 1 (NF1), a rare neurogenetic disorder (incidence 1:2500) at the interface of neurology, oncology, and dermatology. Dr. Verma’s core expertise is in the development of smallmolecule drugs, and  additional  areas  of experience include chemical biology, R&D projectmanagement, and clinical development, for oncology and rare diseases.  Prior to joining Johns HopkinsUniversity, Dr. Verma was in the pharmaceutical industry for nearly 15 years first working at Bayer and laterGlaxoSmithKline, serving in various R&D leadership roles in discovery and clinical development.During his industry tenure, Dr. Verma was a member of multiple project teams, which delivered atotal of 6 clinical development candidates (1 FDA approved), of which he was a leader for 2 of theprograms.  Dr. Verma is a reviewer for multiple scientific journals, a scientific consultant, and has been a reviewer on various  NIH study sections. A native of the San Francisco bay area, Dr. Verma has a BS from the University of California, San Diego, a PhD inChemistry from the University of California, Irvine, and was a NIH Postdoctoral fellow at the University of California, Berkeley (Go Bears!).

STRATEGIC PARTNER

VA_Seal_US_Dept

GOLD SPONSOR

SAMSUNG WORDMARK LOGO - BLACK copy

BLUE SPONSOR

JJI-JLabs_CMYK_300dpi

Prizes, In-Kind, and Media Sponsors

Atrius Health Logo
DavidMCJuFoundation_logoCMYK_stacked
linQ-idea2 black
MIT-InnovationInitiative-Logo_04-20-16_02
1200px-Mitre_Corporation_logo.svg
August 2-4, 2019

Samsung Solutions Center
Washington DC, USA

Schedule

Schedule subject to change. Check back regularly for more details!

Time Event Details
6:00 PM Registration opens
7:00 PM Event kickoff – Opening presentations
8:45 PM Breakout participant pitching session
10:00 PM Team formation
11:00 PM Friday events end 

Time Event Details
8:30 AM Breakfast
9:00 AM Saturday Kick-off
12:00 PM Team Registration
12:00 PM Lunch
6:00 PM Dinner
7:00 PM Practice Pitches
10:00 PM Formal event ends
Time Event Details
8:00 AM Breakfast
9:00 AM Practice Pitches
11:30 AM Lunch
1:00 PM Final Presentations (3 min presentations + 2 min Q&A)
3:30 PM Prizes presented
5:00 PM Event ends
Atrius Health Logo